Celanese declares force majeure for some products sold in Western Hemisphere
Adds executive comment and details on impact in paragraphs 2-4
June 7 (Reuters) -Chemicals firm Celanese CE.N said on Friday it has declared force majeure and sales control for its acetic acid and vinyl acetate monomer (VAM) products sold in the Western Hemisphere due to raw materials shortages and operational issues.
"We anticipate that our second quarter U.S. Gulf Coast production of acetic acid and VAM will be negatively impacted by 15% to 20% as a result of these temporary challenges which we are still navigating," Mark Murray, senior vice president of Celanese's acetyl chain, said.
The company said it took the decision due to intensifying force majeure conditions and operational failures experienced by multiple suppliers of critical raw materials essential to its production.
Celanese warned there could also be volume impact in the second quarter depending on the magnitude of lost production.
Reporting by Tanay Dhumal in Bengaluru; Editing by Shounak Dasgupta
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
